Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05841550
Title The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Oslo University Hospital
Indications
Therapies
Age Groups: senior | adult
Covered Countries NOR

Facility Status City State Zip Country Details
Oslo Myeloma Center RECRUITING Oslo 0450 Norway Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field